三阴性乳腺癌的综合性多原子分析,以确定合适的治疗方法
Bojana Jovanović1,2,3, Sarah E Church4, Kara M Gorman4
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
概括
三重阴性乳腺癌 (TNBC) 是具有侵略性的. 这项研究在95例TNBC病例中将基因组,转录组和蛋白质生物标志物相关联,揭示了针对性治疗的新见解和了解生物标志物相互作用.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物标志物发现发现
背景情况:
- 三重阴性乳腺癌 (TNBC) 是一种异质的恶性瘤,预后不佳.
- 新型疗法往往针对特定的生物标志物,但它们的相关性不太清楚.
研究的目的:
- 调查TNBC中各种生物标志物之间的相互关联.
- 识别潜在的治疗点,了解它们的分子基础.
主要方法:
- 95个TNBC病例的多式模式分析.
- 通过H&E染色对瘤透性淋巴细胞 (TILs) 的量化.
- 通过IHC评估视网膜母细胞瘤 (RB),雄激素受体 (AR) 和PDL1蛋白表达.
- 转录基因分析 (纳米链BC360) 和向DNA测序.
- 对与整体存活率相关性的评估.
主要成果:
- RB1 mRNA和蛋白质水平与视网膜母细胞瘤的功能性比突变状态更好地相关.
- 发光性AR瘤分为基底类和介质细胞类的转录组亚型.
- 具有PDL1阳性的瘤表现出类似的生物特征.
- 低HER2的TNBC没有表现出明显的表型.
- 大多数TNBC是基底或HER2丰富的 (PAM50),HER2丰富的显示了更好的生存率.
结论:
- 该研究提供了对TNBC治疗选择生物标志物的实用性的见解.
- 在TNBC中揭示了基因组,转录组,蛋白质和细胞生物标志物之间的相互关联.
- 建立一个数据资源,以进一步探索TNBC中的生物标志物相互作用.
更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.9K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K